Showing results (51-60 of 76) with videos related to

Sort By:
Pageof 8
International Journal of Cancer|August 14, 1999
Lack of modulation of MDR1 gene expression by dominant inhibition of cAMP-dependent protein kinase in doxorubicin-resistant MCF-7 breast cancer cellsA M Parissenti, B R Gannon, D J Villeneuve, et al.
Bone Marrow Transplantation|October 6, 1997
High-dose chemotherapy followed by autologous blood cell transplantation: a safe and effective outpatient approachS Glück, C des Rochers, C Cano, et al.
European Journal of Cancer (Oxford, England : 1990)|December 16, 1998
A phase I trial of high-dose paclitaxel, cyclophosphamide and mitoxantrone with autologous blood stem cell support for the treatment of metastatic breast cancerS Glück, C Germond, P Lopez, et al.
Bone Marrow Transplantation|July 31, 2001
HER-2 expression is a prognostic factor in patients with metastatic breast cancer treated with a combination of high-dose cyclophosphamide, mitoxantrone, paclitaxel and autologous blood stem cell supportM Bewick, M Conlon, S Gerard, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|March 21, 1998
Decrease in tumor cell contamination and progenitor cell yield in leukapheresis products after consecutive cycles of chemotherapy for breast cancer treatmentS Glück, A A Ross, T J Layton, et al.
International Archives of Allergy and Applied Immunology|January 1, 1985
The human adenoidal mast cell. Susceptibility to different secretagogues and secretion inhibitorsW Schmutzler, K Delmich, D Eichelberg, et al.
Der Ophthalmologe : Zeitschrift Der Deutschen Ophthalmologischen Gesellschaft|November 30, 2020
[Impact of a more stringent organization of intravitreal injection treatment on the number of treatments and examinations in routine practice]S Glück, U Brandlhuber, R Gerbutavicius, et al.
Onkologie|June 1, 1986
Current results of a multicenter trial in multiple myelomaD Peest, H J Schmoll, I Schedel, et al.
Bone Marrow Transplantation|September 12, 2000
Double high-dose therapy for Hodgkin's disease with dose-intensive cyclophosphamide, etoposide, and cisplatin (DICEP) prior to high-dose melphalan and autologous stem cell transplantationD A Stewart, D Guo, S Glück, et al.
Bone Marrow Transplantation|July 15, 2003
Micrometastases in apheresis products predict shorter progression-free and overall survival in patients with breast cancer undergoing high-dose chemotherapy (HDCT) and autologous blood stem cell transplantation (ABSCT)R Syme, D Stewart, M Rodriguez-Galvez, et al.
Pageof 8